Literature DB >> 12948016

Effect of the flavonoids biochanin A and silymarin on the P-glycoprotein-mediated transport of digoxin and vinblastine in human intestinal Caco-2 cells.

Shuzhong Zhang1, Marilyn E Morris.   

Abstract

PURPOSE: The purpose of this study was to investigate the effects of flavonoids biochanin A and silymarin on intestinal absorption of P-gp substrates by determining their effects on P-gp-mediated efflux in Caco-2 cells.
METHODS: The cellular accumulation and bidirectional transport of digoxin and vinblastine in Caco-2 cells were determined in the presence and absence of flavonoids.
RESULTS: The 1.5-h accumulation of digoxin and vinblastine in Caco-2 cells was significantly increased by 50 microM biochanin A or silymarin, and this effect was flavonoid-concentration dependent. The AP-to-BL transport of digoxin was significantly increased, whereas the BL-to-AP transport was significantly decreased by 50 microM biochanin A or 75 microM silymarin. At 150 microM concentrations of biochanin A or silymarin, mean transport ratios (P(app,B-A)/P(app,A-B)) of 1.62 and 4.48, respectively, compared with the control ratio of 43.4, were obtained.
CONCLUSION: These results indicate that biochanin A and silymarin can inhibit P-gp-mediated efflux in Caco-2 cells, suggesting they could potentially increase the absorption/bioavailability of coadministered drugs that are P-gp substrates.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12948016     DOI: 10.1023/a:1025044913766

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  36 in total

Review 1.  Biochemical, cellular, and pharmacological aspects of the multidrug transporter.

Authors:  S V Ambudkar; S Dey; C A Hrycyna; M Ramachandra; I Pastan; M M Gottesman
Journal:  Annu Rev Pharmacol Toxicol       Date:  1999       Impact factor: 13.820

2.  The effects of dietary supplementation with isoflavones from red clover on the lipoprotein profiles of post menopausal women with mild to moderate hypercholesterolaemia.

Authors:  J B Howes; D Sullivan; N Lai; P Nestel; S Pomeroy; L West; J A Eden; L G Howes
Journal:  Atherosclerosis       Date:  2000-09       Impact factor: 5.162

Review 3.  Pharmacological insights from P-glycoprotein knockout mice.

Authors:  A H Schinkel
Journal:  Int J Clin Pharmacol Ther       Date:  1998-01       Impact factor: 1.366

Review 4.  P-glycoprotein--a mediator of multidrug resistance in tumour cells.

Authors:  U A Germann
Journal:  Eur J Cancer       Date:  1996-06       Impact factor: 9.162

Review 5.  Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy.

Authors:  V J Wacher; C Y Wu; L Z Benet
Journal:  Mol Carcinog       Date:  1995-07       Impact factor: 4.784

6.  P-glycoprotein-mediated transport of berberine across Caco-2 cell monolayers.

Authors:  Han-Joo Maeng; Ho-Jung Yoo; In-Wha Kim; Im-Sook Song; Suk-Jae Chung; Chang-Koo Shim
Journal:  J Pharm Sci       Date:  2002-12       Impact factor: 3.534

7.  Effect of milk thistle on the pharmacokinetics of indinavir in healthy volunteers.

Authors:  Stephen C Piscitelli; Elizabeth Formentini; Aaron H Burstein; Raul Alfaro; Shyla Jagannatha; Judith Falloon
Journal:  Pharmacotherapy       Date:  2002-05       Impact factor: 4.705

Review 8.  The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer.

Authors:  E Middleton; C Kandaswami; T C Theoharides
Journal:  Pharmacol Rev       Date:  2000-12       Impact factor: 25.468

9.  Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833.

Authors:  U Mayer; E Wagenaar; B Dorobek; J H Beijnen; P Borst; A H Schinkel
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

10.  Silymarin, a naturally occurring polyphenolic antioxidant flavonoid, inhibits azoxymethane-induced colon carcinogenesis in male F344 rats.

Authors:  Hiroyuki Kohno; Takuji Tanaka; Kunihiro Kawabata; Yoshinobu Hirose; Shigeyuki Sugie; Hiroyuki Tsuda; Hideki Mori
Journal:  Int J Cancer       Date:  2002-10-10       Impact factor: 7.396

View more
  23 in total

1.  Herb-drug interactions: challenges and opportunities for improved predictions.

Authors:  Scott J Brantley; Aneesh A Argikar; Yvonne S Lin; Swati Nagar; Mary F Paine
Journal:  Drug Metab Dispos       Date:  2013-12-11       Impact factor: 3.922

2.  Population pharmacokinetics of sirolimus in de novo Chinese adult renal transplant patients.

Authors:  Zheng Jiao; Xiao-jin Shi; Zhong-dong Li; Ming-kang Zhong
Journal:  Br J Clin Pharmacol       Date:  2009-07       Impact factor: 4.335

3.  Interaction Studies of Resolvin E1 Analog (RX-10045) with Efflux Transporters.

Authors:  Kishore Cholkar; Hoang M Trinh; Aswani Dutt Vadlapudi; Zhiying Wang; Dhananjay Pal; Ashim K Mitra
Journal:  J Ocul Pharmacol Ther       Date:  2015-04-06       Impact factor: 2.671

Review 4.  Biochanin a: understanding the complexities in the paradoxical drug-drug interaction potential.

Authors:  Nuggehally R Srinivas
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2015-06       Impact factor: 2.441

5.  Effect of milk thistle on the pharmacokinetics of darunavir-ritonavir in HIV-infected patients.

Authors:  José Moltó; Marta Valle; Cristina Miranda; Samandhy Cedeño; Eugenia Negredo; Bonaventura Clotet
Journal:  Antimicrob Agents Chemother       Date:  2012-03-19       Impact factor: 5.191

6.  Elementary research of the formation mechanism of sex-related fluorescent cocoon of silkworm, Bombyx mori.

Authors:  Hu Xiaolong; Xue Renyu; Cao Guangli; Zhang Xing; Zhang Yilin; Yu Xiaohua; Zhang Yuqing; Gong Chengliang
Journal:  Mol Biol Rep       Date:  2011-05-22       Impact factor: 2.316

7.  Effect of milk thistle (Silybum marianum) and black cohosh (Cimicifuga racemosa) supplementation on digoxin pharmacokinetics in humans.

Authors:  Bill J Gurley; Gary W Barone; D Keith Williams; Julie Carrier; Philip Breen; C Ryan Yates; Peng-fei Song; Martha A Hubbard; Yudong Tong; Sreekhar Cheboyina
Journal:  Drug Metab Dispos       Date:  2005-10-12       Impact factor: 3.922

8.  Monocarboxylate transporter-mediated transport of gamma-hydroxybutyric acid in human intestinal Caco-2 cells.

Authors:  Wing Ki Lam; Melanie A Felmlee; Marilyn E Morris
Journal:  Drug Metab Dispos       Date:  2009-12-01       Impact factor: 3.922

9.  Effect of silymarin supplement on the pharmacokinetics of rosuvastatin.

Authors:  Jian Wei Deng; Ji-Hong Shon; Ho-Jung Shin; Soo-Jin Park; Chang-Woo Yeo; Hong-Hao Zhou; Im-Sook Song; Jae-Gook Shin
Journal:  Pharm Res       Date:  2008-01-31       Impact factor: 4.200

10.  Hepatic metabolism and biliary excretion of silymarin flavonolignans in isolated perfused rat livers: role of multidrug resistance-associated protein 2 (Abcc2).

Authors:  Sonia R Miranda; Jin Kyung Lee; Kim L R Brouwer; Zhiming Wen; Philip C Smith; Roy L Hawke
Journal:  Drug Metab Dispos       Date:  2008-08-07       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.